DREAMseq of therapy for BRAF-mutant melanoma

被引:0
|
作者
David Killock
机构
[1] Nature Reviews Clinical Oncology,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 1
相关论文
共 50 条
  • [1] DREAMseq of therapy for BRAF-mutant melanoma
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (01) : 1 - 1
  • [2] BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
    Qi Liu
    Hongda Zhu
    Yun Liu
    Sara Musetti
    Leaf Huang
    [J]. Cancer Immunology, Immunotherapy, 2018, 67 : 299 - 310
  • [3] BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
    Liu, Qi
    Zhu, Hongda
    Liu, Yun
    Musetti, Sara
    Huang, Leaf
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (02) : 299 - 310
  • [4] Refining Targeted Therapy Opportunities for BRAF-Mutant Melanoma
    Jenkins, Russell W.
    Barbie, David A.
    [J]. CANCER DISCOVERY, 2017, 7 (08) : 799 - 801
  • [5] Inhibition of BRAF and MEK in BRAF-mutant melanoma
    Smalley, Keiran S. M.
    Sondak, Vernon K.
    [J]. LANCET, 2015, 386 (9992): : 410 - 412
  • [6] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    [J]. LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [7] Dabrafenib for treatment of BRAF-mutant melanoma
    Kainthla, Radhika
    Kim, Kevin B.
    Falchook, Gerald S.
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 21 - 29
  • [8] What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF-Mutant Melanoma?
    Sullivan, Ryan J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (36) : 4161 - +
  • [9] Immunotherapy First for BRAF-Mutant Melanoma
    Rose, Suzanne
    [J]. CANCER DISCOVERY, 2022, 12 (01) : 10 - 10
  • [10] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43